AI companies call for strong synthetic DNA and RNA ordering regulation
As AI technology advances rapidly, leading experts warn that the barriers preventing malicious use of synthetic biological materials are eroding, urging immediate legislative action to implement screening and tracking measures.
As artificial intelligence (AI) continues to gain strength, a few of the top AI companies, along with experts in biotechnology, life science, public health, and national security are calling for regulation regarding synthetic DNA and RNA ordering. They sent an Open Letter to U.S. lawmakers, according to a mobi health news article.
The letter warns against misuse, asking for all synthetic DNA and RNA orders to be screened and tracked. The authors said, “AI systems are improving rapidly, and alongside incredible benefits to science and medicine, there is a real possibility that the knowledge barriers which have historically prevented bad actors from obtaining biological weapons will meaningfully erode.” More than 80 experts signed the letter, supporting ordering regulation. They emphasized the urgency of legislation.
